DC
Debjit Chattopadhyay Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
37
Avg Return
Past Year
Past Year
33%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $30 |
213%
upside
| 1 | +13% |
0
%
| 15 Oct ‘25 4 days ago |
|
|
|
Buy
Reiterated
| $28 |
22%
upside
| 1 | +9.5% |
0
%
| 6 Oct ‘25 13 days ago |
|
|
|
Buy
Maintained
| $95 |
64%
upside
| 1 | +92% |
0
%
| 25 Sep ‘25 24 days ago |
|
|
|
Buy
Reiterated
| $6 |
23%
upside
| 2 | +91% |
0
%
| 24 Sep ‘25 25 days ago |
|
|
|
Buy
Maintained
| $92 |
26%
upside
| 1 | +42% |
0
%
| 23 Sep ‘25 26 days ago |
|
|
|
Buy
Reiterated
| $15 |
73%
upside
| 1 | +35% |
0
%
| 22 Sep ‘25 27 days ago |
|
|
|
Buy
Reiterated
| $22 |
2%
downside
| 1 | -17% |
0
%
| 15 Sep ‘25 1 month ago |
|
|
|
Buy
Maintained
| $34 |
22%
upside
| 1 | +49% |
0
%
| 15 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $106 |
62%
upside
| 2 | -0.17% |
0
%
| 27 Aug ‘25 1 month ago |
|
|
|
Buy
Maintained
| $10 |
24%
upside
| 1 | +26% |
0
%
| 14 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $106 |
99%
upside
| 1 | -14% |
0
%
| 6 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $546 |
31%
upside
| 1 | +11% |
0
%
| 6 Aug ‘25 2 months ago |
|